Drug intelligence / Profile preview

dexmedetomidine + lidocaine

Development stage
Unknown
Lead developer
Orion Pharma
Modality
Small Molecules
Administration
Intravenous, Infiltration, Nerve Block
01

Overview

The combination of dexmedetomidine and lidocaine is used in various medical procedures, particularly for sedation and anesthesia. This combination has been studied for its enhanced effects compared to either drug alone. ## Description Dexmedetomidine + lidocaine is a combination of two drugs used primarily in anesthesia and sedation. Dexmedetomidine is a highly selective alpha-2 adrenergic receptor agonist that provides sedative, analgesic, and anxiolytic effects without significant respiratory depression[8]. Lidocaine is a classical local anesthetic that blocks sodium channels to prevent the generation and conduction of nerve impulses[6]. When combined, these drugs demonstrate enhanced effects: - Greater reduction in minimum alveolar concentration (MAC) of isoflurane compared to either drug alone (60.9% reduction for the combination vs. 27.3% for lidocaine alone and 43.4% for dexmedetomidine alone)[2] - Enhanced pulpal anesthetic effect in dental procedures[8] - Better hemodynamic stability during surgical procedures[5] - Improved postoperative analgesia and sedation[5] - Reduced inflammatory stress and stress hormone levels[5] - Lower incidence of postoperative nausea and vomiting[5] The combination has been studied in various procedures including laparoscopic hysterectomy, dental anesthesia, and intracranial aneurysm clipping surgery. ## Mechanisms of Action Dexmedetomidine works primarily as an alpha-2 adrenergic receptor agonist, providing sedation and analgesia through central alpha-2A receptors while also causing vasoconstriction through peripheral alpha-2B receptors[8]. Lidocaine functions as a sodium channel blocker, preventing the generation and conduction of nerve impulses. When used together, these drugs appear to have a combined effect that is greater than the sum of their individual effects, though it's unclear whether this is additive or synergistic[2]. ## Clinical Applications The combination has been studied for: - Dental anesthesia[1][8] - Sedation during surgical procedures[6] - Laparoscopic hysterectomy[5] - Intracranial aneurysm clipping surgery[7] - Reduction of oxidative stress in perioperative patients[7] Research indicates that this combination may be particularly beneficial for patients requiring both sedation and local anesthesia, as it provides enhanced anesthetic effects while maintaining cardiovascular stability. ## Safety Profile The combination appears to be cardiovascularly safe, even in hypertensive patients[1]. However, it can cause: - Prolonged recovery time compared to lidocaine alone[5] - Reduced mean arterial pressure and heart rate[5] - Sedative effects as measured by reduced bispectral index[8] The combination has shown a lower incidence of postoperative nausea and vomiting compared to lidocaine alone (28.0% vs 58.0%)[5].

Other names
dexmédétomidine + lidocaineOFACS protocol
02

Targets

ADRA2A (α2A)SCN10A (Sodium channel protein type X alpha subunit)HCN (HCN channel family)Neuraminidase

Beyond the preview

Go deeper on dexmedetomidine + lidocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dexmedetomidine + lidocaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call